News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,899 Results
Type
Article (2166)
Company Profile (16)
Press Release (19717)
Multimedia
Podcasts (8)
Webinars (1)
Section
Business (6228)
Career Advice (63)
Deals (891)
Drug Delivery (1)
Drug Development (3359)
Employer Resources (3)
FDA (623)
Job Trends (794)
News (10770)
Policy (780)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
Academia (280)
Accelerated approval (2)
Adcomms (3)
Allergies (1)
Alliances (1792)
ALS (27)
Alzheimer's disease (358)
Antibody-drug conjugate (ADC) (18)
Approvals (638)
Artificial intelligence (40)
Autoimmune disease (11)
Automation (3)
Bankruptcy (7)
Best Places to Work (762)
Biosimilars (5)
Biotechnology (11)
Brain cancer (7)
Breast cancer (4)
Cancer (98)
Cardiovascular disease (5)
Career advice (51)
Career pathing (2)
CAR-T (5)
CDC (2)
Cell therapy (16)
Cervical cancer (3)
Clinical research (2816)
Collaboration (110)
Compensation (33)
Complete response letters (2)
COVID-19 (52)
CRISPR (1)
C-suite (72)
Data (337)
Denatured (1)
Depression (68)
Diabetes (4)
Diagnostics (86)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (3)
Duchenne muscular dystrophy (8)
Earnings (1637)
Editorial (5)
Employer branding (1)
Employer resources (3)
Events (3172)
Executive appointments (82)
FDA (768)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (90)
Gene editing (1)
Gene therapy (26)
GLP-1 (38)
Government (89)
Guidances (31)
Healthcare (634)
Huntington's disease (8)
IgA nephropathy (6)
Immunology and inflammation (21)
Immuno-oncology (3)
Indications (6)
Infectious disease (53)
Inflammatory bowel disease (12)
Inflation Reduction Act (1)
Intellectual property (7)
Interviews (12)
IPO (325)
IRA (1)
Job creations (99)
Job search strategy (46)
JPM (14)
Labor market (1)
Layoffs (28)
Leadership (1)
Legal (101)
Liver cancer (1)
Longevity (3)
Lung cancer (10)
Lymphoma (10)
Machine learning (1)
Management (1)
Manufacturing (26)
MASH (1)
Medical device (281)
Medtech (285)
Mergers & acquisitions (632)
Metabolic disorders (23)
Multiple sclerosis (41)
Neurodegenerative disease (72)
Neuropsychiatric disorders (39)
Neuroscience (844)
Neurotech (1)
NextGen: Class of 2026 (244)
Non-profit (224)
Now hiring (4)
Obesity (17)
Opinion (11)
Ovarian cancer (5)
Pain (14)
Pancreatic cancer (6)
Parkinson's disease (79)
Patents (18)
Patient recruitment (18)
People (2803)
Pharmaceutical (2)
Phase 1 (640)
Phase 2 (1069)
Phase 3 (1273)
Pipeline (308)
Policy (7)
Postmarket research (133)
Preclinical (395)
Prostate cancer (3)
Psychedelics (11)
Radiopharmaceuticals (6)
Rare diseases (38)
Real estate (168)
Recruiting (1)
Regulatory (749)
Research institute (243)
Resumes & cover letters (9)
Rett syndrome (5)
RNA editing (1)
RSV (1)
Schizophrenia (83)
Series A (19)
Series B (13)
Sickle cell disease (2)
Special edition (5)
Spinal muscular atrophy (33)
Sponsored (1)
Startups (147)
Stomach cancer (1)
Supply chain (1)
Tariffs (3)
The Weekly (7)
Vaccines (15)
Venture capital (12)
Weight loss (6)
Women's health (1)
Date
Today (12)
Last 7 days (37)
Last 30 days (127)
Last 365 days (1526)
2026 (210)
2025 (1513)
2024 (1614)
2023 (1684)
2022 (1907)
2021 (2148)
2020 (1674)
2019 (1422)
2018 (1075)
2017 (1076)
2016 (1073)
2015 (1228)
2014 (880)
2013 (659)
2012 (659)
2011 (560)
2010 (490)
Location
Africa (29)
Alabama (2)
Arizona (8)
Arkansas (1)
Asia (1535)
Australia (199)
California (630)
Canada (168)
China (69)
Colorado (16)
Connecticut (57)
Delaware (6)
Europe (3535)
Florida (83)
Georgia (4)
Idaho (2)
Illinois (121)
Indiana (29)
Japan (28)
Kentucky (1)
Louisiana (1)
Maine (4)
Maryland (67)
Massachusetts (476)
Michigan (2)
Minnesota (16)
Missouri (1)
Montana (3)
Nebraska (1)
Nevada (3)
New Hampshire (3)
New Jersey (114)
New Mexico (1)
New York (222)
North Carolina (27)
Northern California (237)
Ohio (11)
Pennsylvania (93)
Puerto Rico (1)
Rhode Island (2)
South America (20)
South Carolina (1)
Southern California (333)
Tennessee (4)
Texas (32)
United States (2002)
Utah (12)
Virginia (4)
Washington D.C. (4)
Washington State (29)
Wisconsin (4)
21,899 Results for "aspen neuroscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
November 21, 2025
·
4 min read
Press Releases
Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients
January 9, 2026
·
4 min read
Press Releases
Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late‑Stage Development and Commercial Readiness
January 8, 2026
·
4 min read
Press Releases
Aspen Neuroscience Initiates Cohort 3 in ASPIRO Phase 1/2a Trial, Highlighting Commercial Formulation of ANPD001 and Its Transformative Potential for Parkinson’s Disease
September 26, 2025
·
4 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 14, 2025
·
2 min read
Press Releases
Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting
June 9, 2025
·
2 min read
Press Releases
Aspen Neuroscience to Present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting
May 7, 2025
·
4 min read
Biotech Beach
Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Aspen Neuroscience will present this week to a global audience of clinicians, regulators, researchers, technologists and industry partners at the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, May 29-June 1.
May 30, 2024
·
3 min read
1 of 2,190
Next
